Brief: Decibel Therapeutics To Present DB-020 Phase 1b Clinical Trial Data
01/06/2023 22:40
June 1 (Reuters) - Decibel Therapeutics Inc DBTX.O :
* DECIBEL THERAPEUTICS TO PRESENT DB-020 PHASE 1B CLINICAL
TRIAL
DATA AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) 2023
ANNUAL MEETING
Source text for Eikon: ID:nGNXbd9lKp
Further company coverage: DBTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Decibel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Domo, BlackBerry, Rite Aid
U.S. STOCKS ON THE MOVE-Decibel Therapeutics, Affirm Holdings, Medtronic
Decibel rises on FDA's 'fast-track' tag for hearing-loss therapy
Brief: Decibel Therapeutics Says US Food And Drug Administration Had Granted Fast Track Designation For DB-OTO
Decibel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary